Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06329388 · ClinicalTrials.gov registry record · Phase 1

Evaluating the Effects of an Oral Protein Supplement on Children's Growth Patterns

A Phase 1 study of Child Development and Body Weight, sponsored by TruHeight Vitamins.

Completed
Registry status
Phase 1
Development phase
32
Enrollment target
1
Study location

NCT06329388 is a Phase 1 study of Child Development and Body Weight that has completed, run by TruHeight Vitamins. The registered enrollment target is 32 participants, below the 1,092-participant average among 32 other Child Development trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06329388, a Phase 1 study of Child Development and Body Weight, has completed, sponsored by TruHeight Vitamins.

COMPLETED
Registry status
Phase 1
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

This single-center, randomized controlled pilot study aims to evaluate the efficacy of TruHeight Growth Protein Shake on improving growth patterns in children aged 4-17 years. Over six months, participants will consume the protein shake daily, five times a week, with outcomes measured in terms of type X collagen concentration in urine, height via a stadiometer, and body composition using an INBODY device.

Interventions

  • DIETARY_SUPPLEMENT TruHeight Growth Protein Shake

Study Locations (1)

California

  • SF Research Institute - San Francisco

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2023-01-18
Est. Completion 2023-08-11
Phase Phase 1

Sponsor

TruHeight Vitamins

1 total trials

What the Registry Record Tells You About NCT06329388

The ClinicalTrials.gov registry entry for NCT06329388 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,092-participant average among 32 other Child Development trials with a reported enrollment target (97% lower). The listed sponsor is TruHeight Vitamins, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Child Development appearing as the primary indexed condition, and to 1 intervention - of which TruHeight Growth Protein Shake is the first listed.

NCT06329388 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06329388 about?

NCT06329388 is a clinical study titled "Evaluating the Effects of an Oral Protein Supplement on Children's Growth Patterns". This single-center, randomized controlled pilot study aims to evaluate the efficacy of TruHeight Growth Protein Shake on improving growth patterns in children aged 4-17 years. Over six months, participants will consume the protein shake daily, five times a week, with outcomes measured in terms of ty...

What is the current status of trial NCT06329388?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 32 participants. The study started on 2023-01-18. Estimated completion is 2023-08-11.

What conditions does trial NCT06329388 study?

This clinical trial studies the following conditions: Child Development, Body Weight, Growth Disorders, Dietary Exposure, Bone Development Abnormal.

What interventions are being tested in trial NCT06329388?

The interventions under investigation include: TruHeight Growth Protein Shake (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06329388?

This trial is sponsored by TruHeight Vitamins, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06329388 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Child Development

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.